"""Irrigation method"" in prevention and treatment of portal vein hypertension after small-for-size liver transplantation"
10.3760/cma.j.issn.1007-8118.2017.05.012
- VernacularTitle:“灌溉法”防治小体积肝移植后门静脉高压
- Author:
Yanhu FENG
;
Baohong GU
;
Jike HU
;
Zhijian HAN
;
Huijuan CHENG
;
Yumin LI
;
Hao CHEN
;
Fangfei FENG
;
Shusen ZHENG
- Keywords:
Liver transplantation;
Portal vein hypertension;
Small-for-size syndrome;
Reperfusion
- From:
Chinese Journal of Hepatobiliary Surgery
2017;23(5):327-331
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate effective approach to decrease portal venous hypertension and high perfusion of portal vein caused by small-for-size (SFS) liver graft transplantation with the aim of improving hepatocellular microcirculation.Methods Rat models with SFS liver graft (n =62) were well estab lished and divided into SFS group and trans-portal intrabepatic portosystemic shunt (TPIPSS) group.Hemodynamic parameters,histopathologically morphologic changes,postoperative complications,accumulated survival rate were recorded and analyzed.Venous filling time after liver reperfusion,hemodynamic parameters were evaluated using t test and Kruskal-Wallis test.Kaplan-Meier method was performed for survival analysis.Results Venous filling time after liver reperfusion was remarkably prolonged with the application of multihole cone-shaped tubes.Compared with SFS group,the filling time was 4-second longer in TPIPSS.At each endpoints of reperfusion within 90 mins,the portal vein pressures were lowered in the TPIPSS group than those of SFS group.Liver grafts were present with more regular structures in TPIPSS group,with no sign of hepatic sinusoid congestion or irregular clearance extension.In the aspect of postoperative complications,all the rat receivers showed ascites in the SFS group.Nevertheless,there was no ascites observed in TPIPSS rats,and 50％ rats (5/10) experienced clinical manifestations of hepatic encephalopathy.Persistent fever over 7 days was showed in 10％ rats (1/10) of SFS group and 40％ rats (4/10) of TPIPSS group,respectively.The mean survival was superior in TPIPSS group (37.2 ± 23.5) d than SFS group (17.7 ± 13.5) d,P ＜ 0.05.Conclusion TPIPSS could be a safe and feasible approach to improve portal venous hypertension caused by SFS liver graft and hepatocellular reperfusion.
